Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxd8
|
ENSMUSG00000027102.4 | homeobox D8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_74703955_74704159 | Hoxd8 | 558 | 0.421633 | -0.14 | 3.2e-01 | Click! |
chr2_74704239_74704458 | Hoxd8 | 267 | 0.712534 | -0.13 | 3.4e-01 | Click! |
chr2_74704808_74704978 | Hoxd8 | 12 | 0.910485 | -0.11 | 4.3e-01 | Click! |
chr2_74705947_74706125 | Hoxd8 | 884 | 0.252634 | -0.09 | 5.3e-01 | Click! |
chr2_74705741_74705913 | Hoxd8 | 675 | 0.347757 | -0.07 | 6.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_79690079_79691459 | 40.76 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr1_24612739_24612914 | 22.27 |
Gm10222 |
predicted gene 10222 |
126 |
0.59 |
chr19_43767999_43768210 | 18.20 |
Cutc |
cutC copper transporter |
3231 |
0.18 |
chr3_144198270_144199266 | 17.97 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr5_129974852_129975023 | 16.71 |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
2057 |
0.19 |
chr16_72699156_72700074 | 16.56 |
Robo1 |
roundabout guidance receptor 1 |
36411 |
0.24 |
chr2_119566179_119566455 | 15.84 |
Chp1 |
calcineurin-like EF hand protein 1 |
288 |
0.85 |
chr17_47909349_47909983 | 14.54 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr10_69253249_69253618 | 13.88 |
Rhobtb1 |
Rho-related BTB domain containing 1 |
12204 |
0.19 |
chr13_85126661_85127037 | 13.84 |
Gm4076 |
predicted gene 4076 |
665 |
0.69 |
chr7_133988507_133988680 | 13.80 |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
27328 |
0.2 |
chr7_126975552_126976438 | 13.80 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr1_86479174_86479713 | 13.29 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr17_28828817_28829152 | 13.22 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
902 |
0.41 |
chr2_105769867_105770156 | 12.96 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
44311 |
0.13 |
chr13_43480925_43481874 | 12.94 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr5_115436438_115437458 | 12.92 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr11_49713043_49713524 | 12.89 |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
560 |
0.67 |
chr3_60472720_60472916 | 12.86 |
Mbnl1 |
muscleblind like splicing factor 1 |
12 |
0.99 |
chr1_185731219_185731388 | 12.42 |
Gm38093 |
predicted gene, 38093 |
13500 |
0.27 |
chr1_84960126_84960364 | 12.23 |
AC167036.1 |
novel protein |
1263 |
0.35 |
chr10_79814385_79814560 | 11.98 |
Palm |
paralemmin |
190 |
0.84 |
chr4_117055827_117056105 | 11.93 |
Eif2b3 |
eukaryotic translation initiation factor 2B, subunit 3 |
10505 |
0.09 |
chr6_9834968_9835442 | 11.86 |
Gm5110 |
predicted gene 5110 |
337649 |
0.01 |
chr4_117136303_117136464 | 11.78 |
Plk3 |
polo like kinase 3 |
2420 |
0.1 |
chr2_170158021_170158172 | 11.58 |
Zfp217 |
zinc finger protein 217 |
9993 |
0.28 |
chr17_21473484_21473684 | 11.55 |
Zfp53 |
zinc finger protein 53 |
15414 |
0.1 |
chr15_98608664_98610204 | 11.53 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr6_135166144_135166455 | 11.34 |
Hebp1 |
heme binding protein 1 |
1836 |
0.21 |
chr5_14987708_14988443 | 11.32 |
Gm10354 |
predicted gene 10354 |
9140 |
0.21 |
chr16_55816469_55816872 | 11.32 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1845 |
0.33 |
chr1_21660699_21661216 | 11.28 |
Gm7658 |
predicted gene 7658 |
147901 |
0.04 |
chr14_48445875_48446199 | 11.23 |
Tmem260 |
transmembrane protein 260 |
87 |
0.96 |
chr17_84153970_84154239 | 11.17 |
Gm19696 |
predicted gene, 19696 |
2322 |
0.26 |
chr6_146981244_146981874 | 11.01 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
5076 |
0.15 |
chr13_62952253_62952404 | 10.92 |
Gm48812 |
predicted gene, 48812 |
2886 |
0.22 |
chr1_173844562_173844713 | 10.91 |
Gm38050 |
predicted gene, 38050 |
6143 |
0.14 |
chr10_21295422_21295685 | 10.88 |
Hbs1l |
Hbs1-like (S. cerevisiae) |
426 |
0.79 |
chr4_80002679_80002838 | 10.81 |
Gm11407 |
predicted gene 11407 |
427 |
0.69 |
chr12_79856612_79856969 | 10.80 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
67943 |
0.11 |
chr17_56036249_56036917 | 10.78 |
Sh3gl1 |
SH3-domain GRB2-like 1 |
7 |
0.94 |
chr11_96303094_96303989 | 10.75 |
Hoxb5 |
homeobox B5 |
29 |
0.92 |
chr12_111817099_111817250 | 10.56 |
Zfyve21 |
zinc finger, FYVE domain containing 21 |
918 |
0.42 |
chr4_136143104_136143903 | 10.43 |
Id3 |
inhibitor of DNA binding 3 |
6 |
0.97 |
chr1_78203643_78204022 | 10.39 |
Pax3 |
paired box 3 |
6698 |
0.23 |
chr2_110085704_110086138 | 10.33 |
Ccdc34os |
coiled-coil domain containing 34, opposite strand |
35442 |
0.16 |
chr6_124683590_124683741 | 10.31 |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
17754 |
0.06 |
chr11_44512552_44512737 | 10.25 |
Rnf145 |
ring finger protein 145 |
6320 |
0.18 |
chr13_23697544_23698095 | 10.23 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr5_15041810_15042547 | 10.23 |
Gm17019 |
predicted gene 17019 |
9180 |
0.25 |
chr10_81095067_81095218 | 10.23 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
2567 |
0.11 |
chr4_142049656_142049814 | 10.10 |
Gm13053 |
predicted gene 13053 |
1157 |
0.39 |
chr2_78718517_78718735 | 10.06 |
Gm14463 |
predicted gene 14463 |
61197 |
0.13 |
chr18_42510920_42511513 | 9.99 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr3_52938291_52938546 | 9.97 |
Gm20750 |
predicted gene, 20750 |
10752 |
0.18 |
chr8_33987076_33987405 | 9.94 |
Gm45817 |
predicted gene 45817 |
40 |
0.96 |
chr6_52163698_52164573 | 9.92 |
Hoxa2 |
homeobox A2 |
696 |
0.33 |
chr17_62748944_62749123 | 9.91 |
Efna5 |
ephrin A5 |
132111 |
0.06 |
chr10_115263315_115263511 | 9.87 |
Gm8942 |
predicted gene 8942 |
6565 |
0.17 |
chr10_84597482_84597647 | 9.82 |
Tcp11l2 |
t-complex 11 (mouse) like 2 |
2911 |
0.18 |
chr5_125291456_125291674 | 9.67 |
Scarb1 |
scavenger receptor class B, member 1 |
2544 |
0.24 |
chr5_76441429_76441712 | 9.67 |
Gm42665 |
predicted gene 42665 |
10204 |
0.16 |
chr8_84388875_84389036 | 9.61 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
515 |
0.75 |
chr12_91383684_91384259 | 9.60 |
Cep128 |
centrosomal protein 128 |
382 |
0.63 |
chr7_100559420_100559571 | 9.51 |
Mrpl48 |
mitochondrial ribosomal protein L48 |
11875 |
0.09 |
chr2_29683306_29683623 | 9.43 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
19018 |
0.15 |
chr13_95525489_95525667 | 9.43 |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
351 |
0.85 |
chr3_157732464_157732921 | 9.40 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
chr4_87805858_87806167 | 9.38 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
282 |
0.95 |
chr18_56871340_56871513 | 9.31 |
Gm18087 |
predicted gene, 18087 |
44662 |
0.14 |
chr14_26593397_26593744 | 9.27 |
Dennd6a |
DENN/MADD domain containing 6A |
11101 |
0.12 |
chr2_154765762_154765945 | 9.22 |
Gm14214 |
predicted gene 14214 |
4079 |
0.16 |
chr19_10014816_10015132 | 9.19 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
42 |
0.96 |
chr9_50739248_50739758 | 9.17 |
Dixdc1 |
DIX domain containing 1 |
14 |
0.96 |
chr15_53202107_53202269 | 9.09 |
Ext1 |
exostosin glycosyltransferase 1 |
5933 |
0.34 |
chr1_135250606_135250761 | 9.06 |
Gm26642 |
predicted gene, 26642 |
2122 |
0.2 |
chr13_22020931_22021318 | 8.99 |
Gm11290 |
predicted gene 11290 |
3618 |
0.06 |
chr3_82809967_82810130 | 8.94 |
Gm43348 |
predicted gene 43348 |
2186 |
0.32 |
chr3_118594373_118594524 | 8.94 |
Dpyd |
dihydropyrimidine dehydrogenase |
32262 |
0.16 |
chr12_72437630_72438246 | 8.88 |
Lrrc9 |
leucine rich repeat containing 9 |
3928 |
0.24 |
chr5_143405415_143405566 | 8.87 |
Kdelr2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
1652 |
0.17 |
chr4_119189502_119189669 | 8.81 |
Ermap |
erythroblast membrane-associated protein |
366 |
0.73 |
chr13_119493187_119493525 | 8.76 |
Tmem267 |
transmembrane protein 267 |
4496 |
0.15 |
chr17_71235938_71236335 | 8.73 |
Lpin2 |
lipin 2 |
2526 |
0.24 |
chr2_125278458_125278642 | 8.73 |
A530010F05Rik |
RIKEN cDNA A530010F05 gene |
3986 |
0.2 |
chr3_106494529_106494709 | 8.69 |
Dennd2d |
DENN/MADD domain containing 2D |
1444 |
0.31 |
chr11_100938783_100940230 | 8.65 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr9_75927530_75927870 | 8.63 |
Gm44355 |
predicted gene, 44355 |
16278 |
0.16 |
chr1_177475904_177476057 | 8.59 |
Gm37306 |
predicted gene, 37306 |
8602 |
0.17 |
chr8_27058344_27058703 | 8.47 |
Plpbp |
pyridoxal phosphate binding protein |
7749 |
0.11 |
chr4_96273594_96273899 | 8.47 |
Cyp2j15-ps |
cytochrome P450, family 2, subfamily j, member 15, pseudogene |
524 |
0.79 |
chr8_124248816_124249016 | 8.42 |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
17408 |
0.17 |
chr17_79918069_79918346 | 8.41 |
Gm6552 |
predicted gene 6552 |
16365 |
0.16 |
chr7_115501491_115501878 | 8.41 |
Sox6 |
SRY (sex determining region Y)-box 6 |
96212 |
0.09 |
chr15_100400683_100400834 | 8.36 |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
2485 |
0.17 |
chr13_64155195_64155660 | 8.36 |
Zfp367 |
zinc finger protein 367 |
2225 |
0.18 |
chr15_85311204_85311355 | 8.33 |
Atxn10 |
ataxin 10 |
24966 |
0.17 |
chr12_80776376_80776562 | 8.24 |
Gm47941 |
predicted gene, 47941 |
13874 |
0.11 |
chr6_144648575_144648726 | 8.23 |
Sox5it |
SRY (sex determining region Y)-box 5, intronic transcript |
24070 |
0.17 |
chr2_103896151_103896680 | 8.21 |
Gm13876 |
predicted gene 13876 |
8091 |
0.12 |
chr2_132924073_132924224 | 8.15 |
Fermt1 |
fermitin family member 1 |
17815 |
0.14 |
chr2_129214608_129214759 | 8.13 |
A730036I17Rik |
RIKEN cDNA A730036I17 gene |
4286 |
0.11 |
chr17_71290525_71291000 | 8.13 |
Emilin2 |
elastin microfibril interfacer 2 |
6485 |
0.15 |
chr2_172448720_172448871 | 8.08 |
Rtf2 |
replication termination factor 2 |
4182 |
0.15 |
chr5_66337123_66338408 | 8.08 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
83 |
0.96 |
chr10_54042474_54042667 | 8.03 |
Gm47917 |
predicted gene, 47917 |
21241 |
0.18 |
chr4_33471238_33471389 | 8.02 |
Gm11935 |
predicted gene 11935 |
18424 |
0.21 |
chr3_98044876_98045059 | 8.02 |
Gm42819 |
predicted gene 42819 |
14280 |
0.18 |
chr17_15031604_15031783 | 7.98 |
Ermard |
ER membrane associated RNA degradation |
9515 |
0.12 |
chr7_115830920_115831237 | 7.93 |
Sox6 |
SRY (sex determining region Y)-box 6 |
6368 |
0.31 |
chr15_38950893_38951406 | 7.88 |
Gm49097 |
predicted gene, 49097 |
12527 |
0.14 |
chr7_103865311_103865713 | 7.87 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12296 |
0.06 |
chr6_120605559_120605721 | 7.87 |
Gm44124 |
predicted gene, 44124 |
25464 |
0.13 |
chr5_140034121_140034770 | 7.85 |
Gm43702 |
predicted gene 43702 |
2269 |
0.28 |
chr17_86301671_86301829 | 7.81 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
14572 |
0.27 |
chr17_14968636_14968823 | 7.80 |
Phf10 |
PHD finger protein 10 |
7456 |
0.11 |
chr13_30109509_30109660 | 7.80 |
Gm11367 |
predicted gene 11367 |
2890 |
0.21 |
chr4_116659565_116659733 | 7.79 |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
7969 |
0.11 |
chr1_85099723_85100032 | 7.74 |
Gm10553 |
predicted gene 10553 |
287 |
0.81 |
chr2_68796050_68796462 | 7.73 |
Gm13612 |
predicted gene 13612 |
34761 |
0.14 |
chr17_15000217_15000406 | 7.73 |
Gm3448 |
predicted gene 3448 |
9858 |
0.11 |
chr7_45103031_45103408 | 7.67 |
Fcgrt |
Fc receptor, IgG, alpha chain transporter |
133 |
0.83 |
chr10_13240589_13240802 | 7.66 |
Gm47402 |
predicted gene, 47402 |
35469 |
0.15 |
chr11_113014293_113014953 | 7.62 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
158454 |
0.04 |
chr8_128350517_128350668 | 7.52 |
Nrp1 |
neuropilin 1 |
8012 |
0.23 |
chr9_63201505_63201702 | 7.51 |
Skor1 |
SKI family transcriptional corepressor 1 |
52642 |
0.12 |
chr1_23335409_23335710 | 7.51 |
Gm20954 |
predicted gene, 20954 |
11040 |
0.15 |
chr4_44042479_44042779 | 7.48 |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
12668 |
0.13 |
chr19_56099822_56100008 | 7.48 |
Gm31912 |
predicted gene, 31912 |
6333 |
0.26 |
chr19_55700934_55701097 | 7.47 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40805 |
0.21 |
chr4_154359614_154359823 | 7.40 |
Prdm16 |
PR domain containing 16 |
11261 |
0.18 |
chr2_169700152_169700461 | 7.38 |
Tshz2 |
teashirt zinc finger family member 2 |
66630 |
0.12 |
chr4_150129048_150129199 | 7.37 |
Slc2a5 |
solute carrier family 2 (facilitated glucose transporter), member 5 |
177 |
0.91 |
chr12_31256586_31256763 | 7.37 |
Gm32899 |
predicted gene, 32899 |
2183 |
0.18 |
chr10_93886358_93886509 | 7.31 |
Metap2 |
methionine aminopeptidase 2 |
1053 |
0.42 |
chr1_118359132_118359293 | 7.27 |
Gm28867 |
predicted gene 28867 |
1900 |
0.3 |
chr10_68781184_68781335 | 7.26 |
Tmem26 |
transmembrane protein 26 |
57435 |
0.14 |
chr2_167713774_167713925 | 7.22 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
22668 |
0.1 |
chr5_15671306_15671850 | 7.19 |
Speer4cos |
spermatogenesis associated glutamate (E)-rich protein 4C, opposite strand transcript |
9132 |
0.16 |
chr18_75005159_75005310 | 7.19 |
Gm50313 |
predicted gene, 50313 |
370 |
0.56 |
chr19_32319980_32320272 | 7.17 |
Sgms1 |
sphingomyelin synthase 1 |
3103 |
0.3 |
chr5_100605807_100606019 | 7.17 |
Gm43510 |
predicted gene 43510 |
13157 |
0.14 |
chr12_105757874_105758401 | 7.13 |
Ak7 |
adenylate kinase 7 |
12862 |
0.17 |
chr6_71130459_71130610 | 7.12 |
Thnsl2 |
threonine synthase-like 2 (bacterial) |
1438 |
0.31 |
chr9_66769338_66769700 | 7.11 |
Car12 |
carbonic anhydrase 12 |
21809 |
0.12 |
chr3_28722237_28722388 | 7.11 |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
795 |
0.59 |
chr7_138913726_138913877 | 7.10 |
Gm9358 |
predicted gene 9358 |
587 |
0.61 |
chr7_65469432_65469612 | 7.09 |
Gm44792 |
predicted gene 44792 |
11699 |
0.21 |
chr13_112316899_112317050 | 7.09 |
Ankrd55 |
ankyrin repeat domain 55 |
1480 |
0.39 |
chr17_12179256_12179781 | 7.08 |
Tdgf1-ps2 |
teratocarcinoma-derived growth factor, pseudogene 2 |
10403 |
0.19 |
chr2_22587496_22588353 | 7.04 |
Gm13341 |
predicted gene 13341 |
38 |
0.95 |
chrX_12135769_12136175 | 7.02 |
Bcor |
BCL6 interacting corepressor |
7572 |
0.26 |
chr5_15464753_15465394 | 7.00 |
Gm43391 |
predicted gene 43391 |
902 |
0.58 |
chr17_70751187_70751409 | 7.00 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
4284 |
0.21 |
chr15_11726187_11726411 | 6.95 |
Gm41271 |
predicted gene, 41271 |
22596 |
0.22 |
chr10_94574788_94575101 | 6.93 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
313 |
0.87 |
chr10_80975511_80975708 | 6.88 |
Gm3828 |
predicted gene 3828 |
20899 |
0.08 |
chr7_143340680_143341191 | 6.88 |
Gm38095 |
predicted gene, 38095 |
3502 |
0.17 |
chr16_90625710_90626231 | 6.88 |
Gm23406 |
predicted gene, 23406 |
23474 |
0.13 |
chr6_134664499_134665111 | 6.84 |
Borcs5 |
BLOC-1 related complex subunit 5 |
23550 |
0.12 |
chr1_85259970_85261058 | 6.83 |
C130026I21Rik |
RIKEN cDNA C130026I21 gene |
1556 |
0.27 |
chr1_74624463_74624614 | 6.80 |
Stk36 |
serine/threonine kinase 36 |
1708 |
0.24 |
chr1_85580713_85581405 | 6.77 |
Sp110 |
Sp110 nuclear body protein |
3219 |
0.13 |
chr6_86636441_86636743 | 6.77 |
Asprv1 |
aspartic peptidase, retroviral-like 1 |
8428 |
0.11 |
chr19_7018486_7018933 | 6.77 |
Fermt3 |
fermitin family member 3 |
636 |
0.49 |
chr12_54985296_54986516 | 6.77 |
Baz1a |
bromodomain adjacent to zinc finger domain 1A |
30 |
0.91 |
chr6_125565069_125565345 | 6.71 |
Vwf |
Von Willebrand factor |
1044 |
0.56 |
chr8_36685476_36685694 | 6.70 |
Dlc1 |
deleted in liver cancer 1 |
47469 |
0.18 |
chr7_141228067_141228640 | 6.68 |
Phrf1 |
PHD and ring finger domains 1 |
431 |
0.62 |
chr10_128779498_128779802 | 6.61 |
Rpsa-ps2 |
ribosomal protein SA, pseudogene 2 |
2400 |
0.13 |
chr2_84529260_84529411 | 6.61 |
Gm13710 |
predicted gene 13710 |
1987 |
0.28 |
chr6_134983342_134983819 | 6.60 |
Apold1 |
apolipoprotein L domain containing 1 |
1862 |
0.26 |
chrX_103616321_103616657 | 6.59 |
Ftx |
Ftx transcript, Xist regulator (non-protein coding) |
346 |
0.76 |
chr9_42463451_42463637 | 6.58 |
Tbcel |
tubulin folding cofactor E-like |
2083 |
0.29 |
chr3_141952957_141953255 | 6.58 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
21583 |
0.27 |
chr13_62888714_62888865 | 6.55 |
Fbp1 |
fructose bisphosphatase 1 |
507 |
0.73 |
chr6_145340611_145341054 | 6.55 |
Gm15707 |
predicted gene 15707 |
24224 |
0.11 |
chr7_70869109_70869264 | 6.52 |
Gm42397 |
predicted gene, 42397 |
1727 |
0.44 |
chr6_120905290_120905444 | 6.52 |
Gm17812 |
predicted gene, 17812 |
3306 |
0.16 |
chr8_4837818_4838009 | 6.51 |
Gm44961 |
predicted gene 44961 |
16683 |
0.13 |
chr14_78048488_78048639 | 6.50 |
Gm19301 |
predicted gene, 19301 |
22154 |
0.15 |
chr4_12627188_12627491 | 6.48 |
Gm37985 |
predicted gene, 37985 |
29951 |
0.25 |
chr16_49777090_49777249 | 6.47 |
Gm15518 |
predicted gene 15518 |
21701 |
0.2 |
chr17_47951483_47951892 | 6.46 |
Gm5228 |
predicted gene 5228 |
15597 |
0.13 |
chr2_155894386_155894537 | 6.45 |
Uqcc1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
16143 |
0.11 |
chr3_96875239_96875430 | 6.42 |
Gpr89 |
G protein-coupled receptor 89 |
874 |
0.48 |
chr7_19119292_19119545 | 6.41 |
Fbxo46 |
F-box protein 46 |
441 |
0.56 |
chr15_103256585_103256800 | 6.41 |
Nfe2 |
nuclear factor, erythroid derived 2 |
1253 |
0.29 |
chrX_93831605_93832731 | 6.41 |
Pdk3 |
pyruvate dehydrogenase kinase, isoenzyme 3 |
33 |
0.98 |
chr4_134165911_134166062 | 6.41 |
Gm27619 |
predicted gene, 27619 |
1909 |
0.19 |
chr13_97825475_97826241 | 6.37 |
Gm41031 |
predicted gene, 41031 |
27 |
0.98 |
chr7_102565747_102565898 | 6.35 |
Trim21 |
tripartite motif-containing 21 |
336 |
0.7 |
chr15_77822081_77822487 | 6.34 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
9053 |
0.15 |
chr6_25664249_25664412 | 6.32 |
Gpr37 |
G protein-coupled receptor 37 |
25462 |
0.25 |
chr13_37859595_37859751 | 6.30 |
Rreb1 |
ras responsive element binding protein 1 |
1739 |
0.39 |
chr1_85112673_85113075 | 6.30 |
A530040E14Rik |
RIKEN cDNA A530040E14 gene |
1062 |
0.3 |
chr8_84197696_84198961 | 6.27 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr13_63039019_63039172 | 6.25 |
Aopep |
aminopeptidase O |
23602 |
0.15 |
chr9_78217062_78217474 | 6.25 |
Gm3126 |
predicted gene 3126 |
2423 |
0.16 |
chr16_76319178_76320114 | 6.24 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
3.3 | 13.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
3.2 | 9.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
3.0 | 9.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
3.0 | 9.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
2.4 | 7.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
2.1 | 8.3 | GO:0021590 | cerebellum maturation(GO:0021590) |
2.0 | 6.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.0 | 3.9 | GO:0045472 | response to ether(GO:0045472) |
1.9 | 9.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.8 | 5.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.8 | 5.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.8 | 5.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.7 | 40.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.7 | 6.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.7 | 8.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.6 | 6.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.6 | 6.5 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
1.6 | 3.2 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.6 | 8.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.6 | 4.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.6 | 4.8 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.6 | 4.7 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
1.5 | 10.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.5 | 4.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.5 | 4.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.5 | 7.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.5 | 8.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.5 | 4.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.5 | 8.8 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
1.4 | 5.7 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.4 | 9.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.4 | 4.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.4 | 2.8 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.4 | 4.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.3 | 6.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.3 | 3.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.3 | 5.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.3 | 5.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.2 | 3.7 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
1.2 | 3.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.2 | 4.6 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.1 | 7.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.1 | 4.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.0 | 2.1 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 3.0 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.0 | 6.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.0 | 3.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.0 | 4.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.0 | 3.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.0 | 1.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
1.0 | 2.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.0 | 3.8 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.9 | 1.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.9 | 2.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 1.9 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.9 | 1.8 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.9 | 5.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.9 | 5.4 | GO:0015871 | choline transport(GO:0015871) |
0.9 | 2.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.9 | 2.6 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.9 | 1.7 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.9 | 3.5 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 0.9 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.8 | 2.5 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 1.7 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.8 | 1.7 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.8 | 2.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.8 | 0.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 1.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.8 | 2.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 3.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.8 | 0.8 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 3.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.8 | 2.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.8 | 2.4 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.8 | 3.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.8 | 4.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 2.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.8 | 2.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.8 | 3.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 9.7 | GO:0097286 | iron ion import(GO:0097286) |
0.7 | 2.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.7 | 1.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.7 | 5.2 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 2.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.7 | 4.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.7 | 5.0 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.7 | 1.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 2.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 5.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.7 | 2.8 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.7 | 3.5 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.7 | 6.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.7 | 3.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.7 | 2.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 0.7 | GO:0072125 | S-shaped body morphogenesis(GO:0072050) negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.6 | 2.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.6 | 7.5 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.6 | 2.5 | GO:0008228 | opsonization(GO:0008228) |
0.6 | 1.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.6 | 0.6 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.6 | 5.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.6 | 1.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 2.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.6 | 5.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.6 | 10.7 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.6 | 1.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 2.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 2.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 1.7 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.6 | 0.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.6 | 5.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 1.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.5 | 3.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 10.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.5 | 2.7 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.5 | 1.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.5 | 2.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 1.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 1.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 5.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 1.1 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.5 | 1.6 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.5 | 1.1 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.5 | 1.6 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.5 | 3.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.5 | 3.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.5 | 0.5 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 2.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.5 | 3.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.5 | 2.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 3.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 1.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.5 | 0.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 3.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 2.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 4.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 2.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 8.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 1.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.5 | 4.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 3.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 3.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.5 | 1.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 0.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.5 | 1.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 1.4 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.5 | 1.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.5 | 2.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 1.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.5 | 1.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 0.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 2.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 0.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 5.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 0.9 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.4 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 2.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 2.2 | GO:0046618 | drug export(GO:0046618) |
0.4 | 1.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 2.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 13.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 2.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 2.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 2.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 0.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.4 | 0.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 0.4 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.4 | 2.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.4 | 1.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 0.8 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 2.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 0.4 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.4 | 0.8 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.4 | 0.8 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.4 | 1.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.4 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.2 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.4 | 2.0 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 1.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 0.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 1.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 6.8 | GO:0060065 | uterus development(GO:0060065) |
0.4 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 1.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 1.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 0.8 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.4 | 0.8 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 0.4 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.4 | 3.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 1.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.4 | 0.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.4 | 2.3 | GO:0000819 | sister chromatid segregation(GO:0000819) |
0.4 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 1.9 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.4 | 3.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 0.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 1.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 1.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 2.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.4 | 1.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 1.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 1.4 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.4 | 1.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 1.8 | GO:0015879 | carnitine transport(GO:0015879) |
0.4 | 2.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.4 | 2.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 0.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 1.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 1.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 5.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 2.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 4.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 0.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 1.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.7 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 0.7 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.3 | 1.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 2.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 6.8 | GO:0006298 | mismatch repair(GO:0006298) |
0.3 | 1.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.3 | 5.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 0.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.3 | 1.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 0.7 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.3 | 6.1 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 1.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.3 | 0.3 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.3 | 1.3 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 0.7 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.3 | 1.0 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.3 | 0.7 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 3.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 1.0 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 1.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 14.9 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.3 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 2.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 0.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.3 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.3 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.3 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 4.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 0.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 0.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.3 | 2.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 2.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 7.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 0.6 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.3 | 0.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.3 | 1.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 1.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 1.9 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 0.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 4.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.9 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 2.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 1.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.3 | 0.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 0.3 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.3 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 0.6 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.3 | 2.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 1.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.9 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 1.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 1.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 0.6 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 3.5 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 1.4 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.3 | 2.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 0.6 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 1.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 2.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 0.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.8 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 1.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 1.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 2.8 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 0.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 0.5 | GO:0021546 | rhombomere development(GO:0021546) |
0.3 | 0.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 0.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.3 | 0.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 1.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.3 | 0.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 2.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.3 | 1.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 0.3 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 0.3 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.3 | 0.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 1.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 3.7 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.3 | 1.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 0.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 0.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 0.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 1.5 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.3 | 0.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 1.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 2.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.3 | 0.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 1.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 0.5 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 9.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 1.3 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.2 | 1.0 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.5 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.2 | 0.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.2 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.2 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 0.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.2 | 1.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 1.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 0.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 1.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 2.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.2 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 0.5 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.2 | 2.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.2 | 1.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 1.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 1.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.2 | 1.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.5 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.7 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 1.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 1.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.2 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 1.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 2.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.7 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.2 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.2 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 2.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.5 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 3.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.7 | GO:1900193 | regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.8 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.2 | 2.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.4 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 3.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 2.9 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 1.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.2 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 3.9 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 2.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 1.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 4.2 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 1.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.2 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.2 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 1.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 0.4 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 6.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 2.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.4 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 1.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.4 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 0.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 4.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.6 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 1.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 8.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 1.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 1.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 1.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.2 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 3.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.4 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.2 | 1.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.6 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.2 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 1.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.9 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.6 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.6 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 2.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 1.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.5 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.2 | 0.4 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.2 | 1.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 1.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 0.5 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 2.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 1.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 1.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.9 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 0.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.2 | 0.3 | GO:0032079 | positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 1.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.2 | GO:0044241 | lipid digestion(GO:0044241) |
0.2 | 0.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 0.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 1.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.2 | 0.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 2.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.5 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 1.3 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 1.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 3.4 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 1.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 1.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 1.8 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 1.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 3.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.6 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 0.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.2 | 0.8 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.8 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 | 0.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.3 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 1.4 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 8.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.2 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.2 | 1.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 1.1 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 1.4 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.2 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 3.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 3.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.5 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.2 | 0.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.7 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.2 | 1.8 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 0.3 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.6 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.6 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.5 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 1.8 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 1.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 1.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.3 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:1903726 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
0.1 | 0.6 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 1.2 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 1.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 4.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 2.5 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 1.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.2 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.1 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 1.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 1.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.3 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.1 | 0.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 1.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 2.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.7 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 7.1 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 3.1 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 1.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 3.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 6.3 | GO:0001889 | liver development(GO:0001889) |
0.1 | 10.0 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.1 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.4 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.8 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.1 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) corticotropin hormone secreting cell differentiation(GO:0060128) cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 1.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.1 | 9.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.3 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 1.2 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 1.6 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 2.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 1.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 1.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.1 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.8 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.1 | 0.7 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.1 | 1.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 1.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.1 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.1 | 2.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.2 | GO:0060903 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.1 | 0.7 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 3.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.6 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.2 | GO:0097205 | renal filtration(GO:0097205) |
0.1 | 1.2 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 1.6 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.1 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 1.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.9 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 2.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 1.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.4 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.3 | GO:1904262 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 4.4 | GO:0050821 | protein stabilization(GO:0050821) |
0.1 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 1.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.5 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 2.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.3 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 0.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.6 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.7 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 1.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.2 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.3 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 1.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.3 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 1.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 1.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 3.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.9 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 1.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 1.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.2 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.1 | 2.0 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.4 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 3.3 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 0.7 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 1.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 1.2 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.8 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 0.4 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.2 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.3 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.2 | GO:0090175 | regulation of establishment of planar polarity(GO:0090175) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 1.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 1.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.1 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.9 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.2 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.6 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.5 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.7 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.1 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.4 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) ureteric bud morphogenesis(GO:0060675) mesonephric tubule morphogenesis(GO:0072171) |
0.1 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.9 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 2.4 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.2 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.2 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.5 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 2.2 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.5 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.8 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.7 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 1.9 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 1.4 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.2 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.1 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 1.9 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.4 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 3.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.2 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 1.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.4 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.1 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 2.0 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.1 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.1 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.6 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 1.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.1 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 0.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.8 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.6 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 1.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 1.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.1 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0090500 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.1 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.1 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.3 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 1.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.6 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.5 | GO:1901992 | positive regulation of mitotic cell cycle phase transition(GO:1901992) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 1.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.2 | GO:0010662 | regulation of striated muscle cell apoptotic process(GO:0010662) |
0.1 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.5 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 4.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 3.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 0.3 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 1.4 | GO:0006096 | glycolytic process(GO:0006096) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 1.2 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.3 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.1 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.1 | 0.4 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.4 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.3 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.1 | 0.3 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.2 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.1 | 0.9 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.9 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.4 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.1 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.3 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.3 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.1 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.1 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.1 | 0.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.1 | GO:0036166 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) phenotypic switching(GO:0036166) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 1.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.3 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0060191 | regulation of lipase activity(GO:0060191) |
0.1 | 0.1 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 1.6 | GO:0015758 | glucose transport(GO:0015758) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.4 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.4 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.3 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0046112 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) nucleobase biosynthetic process(GO:0046112) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 6.8 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 1.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.0 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.0 | 0.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.2 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 1.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.0 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.0 | 0.5 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.4 | GO:0009209 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.0 | 0.3 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 6.2 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.7 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.6 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 1.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 3.5 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.0 | 1.0 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.4 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 6.2 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0030828 | regulation of cGMP biosynthetic process(GO:0030826) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.1 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.0 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 0.2 | GO:0032355 | response to estradiol(GO:0032355) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.2 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.0 | 0.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 1.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 1.9 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.3 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.0 | GO:0072210 | metanephric nephron development(GO:0072210) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.0 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.0 | GO:0048757 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 3.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.0 | 0.1 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.0 | 0.6 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.0 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.6 | GO:0006275 | regulation of DNA replication(GO:0006275) |
0.0 | 0.0 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.2 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.0 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.6 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.0 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.6 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.4 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.0 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.4 | GO:0030810 | positive regulation of nucleotide biosynthetic process(GO:0030810) positive regulation of purine nucleotide biosynthetic process(GO:1900373) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.0 | 0.0 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0051783 | regulation of nuclear division(GO:0051783) |
0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.0 | 0.0 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.0 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.0 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.0 | 0.1 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.0 | 0.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.4 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.0 | 0.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.0 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.7 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0035268 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.0 | GO:0021626 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.0 | 0.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.0 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.0 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.1 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 19.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.0 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.0 | 0.1 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.0 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.0 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.0 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 1.3 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.3 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.0 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.0 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.0 | GO:0048308 | organelle inheritance(GO:0048308) |
0.0 | 0.0 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.0 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.0 | 0.0 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.0 | 0.1 | GO:0030301 | cholesterol transport(GO:0030301) |
0.0 | 0.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.0 | GO:0045078 | interferon-gamma biosynthetic process(GO:0042095) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0043217 | myelin maintenance(GO:0043217) |
0.0 | 0.0 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.0 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 38.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.5 | 6.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.5 | 11.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.5 | 4.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.4 | 1.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.4 | 4.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.3 | 3.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.3 | 6.3 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 5.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.0 | 3.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.0 | 5.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.0 | 2.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.0 | 9.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.9 | 5.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.9 | 1.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.9 | 5.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 4.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.9 | 2.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 9.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.8 | 11.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 4.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.8 | 5.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.7 | 2.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.7 | 2.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.7 | 2.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 1.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 9.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.6 | 6.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 1.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 2.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.6 | 2.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 2.3 | GO:1990357 | terminal web(GO:1990357) |
0.6 | 2.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.6 | 1.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 9.5 | GO:0002102 | podosome(GO:0002102) |
0.5 | 1.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 2.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 2.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 4.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 15.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 1.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 4.7 | GO:0032797 | SMN complex(GO:0032797) |
0.5 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.5 | 2.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 1.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 2.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 2.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 16.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 1.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 1.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 1.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 1.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.4 | 9.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 1.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 0.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 2.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 0.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 1.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 5.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 3.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 4.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 1.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 1.3 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 1.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 1.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 1.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 1.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 18.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 4.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 2.7 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 1.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 2.3 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 12.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 1.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 5.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 2.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 1.0 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.3 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.8 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 2.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 3.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 14.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 11.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 2.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 5.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 4.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 8.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.4 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 0.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 2.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 2.9 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 12.1 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 3.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.9 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 12.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 1.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 4.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 3.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 4.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 2.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 1.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 11.1 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 1.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 2.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 4.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 1.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 8.7 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 4.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 2.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 13.1 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 3.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 23.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 3.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 5.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 0.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.4 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.1 | 1.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.6 | GO:0044448 | cell cortex part(GO:0044448) |
0.1 | 5.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 6.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 38.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 5.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 1.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 5.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 3.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.8 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 1.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 2.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 24.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.1 | 30.2 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 3.2 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 9.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 5.6 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 8.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 1.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 9.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 3.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 2.4 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.2 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 2.1 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 22.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 2.0 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 1.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 1.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.7 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.1 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.3 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 2.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.4 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 61.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 32.3 | GO:0005768 | endosome(GO:0005768) |
0.1 | 5.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.2 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 33.7 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 5.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 3.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 57.2 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.7 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.4 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 1.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 53.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 1.0 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.1 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 2.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 2.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.0 | 1.8 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 96.1 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 34.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.3 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.0 | GO:1902494 | catalytic complex(GO:1902494) |
0.0 | 0.3 | GO:0030496 | midbody(GO:0030496) |
0.0 | 1.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 3.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.0 | 0.2 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.0 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.0 | 0.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.8 | GO:0044437 | vacuolar part(GO:0044437) |
0.0 | 0.1 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.0 | 0.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0098687 | chromosomal region(GO:0098687) |
0.0 | 0.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.0 | GO:0098588 | bounding membrane of organelle(GO:0098588) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 52.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.0 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 31.9 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.1 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.6 | 10.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
2.5 | 48.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.4 | 7.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.3 | 9.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.2 | 8.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.2 | 6.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.0 | 9.8 | GO:0070061 | fructose binding(GO:0070061) |
1.6 | 6.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.5 | 7.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.5 | 10.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.4 | 4.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.4 | 9.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.4 | 5.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.3 | 5.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.3 | 5.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 5.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.2 | 3.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.2 | 3.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.1 | 4.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.1 | 4.4 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
1.1 | 4.2 | GO:0043515 | kinetochore binding(GO:0043515) |
1.0 | 5.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.0 | 3.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.0 | 5.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.9 | 2.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 7.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.9 | 2.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.9 | 5.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.9 | 2.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.9 | 10.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.9 | 2.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.9 | 10.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.8 | 3.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.8 | 1.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.8 | 3.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.8 | 3.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.8 | 1.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.8 | 3.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.8 | 2.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 7.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.8 | 3.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.8 | 2.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 2.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 3.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 2.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.7 | 5.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.7 | 6.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.7 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 4.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 3.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 5.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 3.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.6 | 3.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 16.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.6 | 1.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.6 | 1.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 2.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 1.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.6 | 16.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 6.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 1.6 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 3.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 2.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 1.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.5 | 3.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 5.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 7.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.5 | 1.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.5 | 2.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 1.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.5 | 2.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.5 | 3.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 1.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 0.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.5 | 14.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 1.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 1.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 1.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 9.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 6.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 2.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 2.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 1.3 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 3.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 2.5 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 2.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 0.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 1.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 2.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 1.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 1.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 5.0 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.4 | 3.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.4 | 4.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 3.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 8.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 1.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 0.7 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 1.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 3.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 0.7 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.4 | 3.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 2.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 5.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.0 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 0.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 2.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 3.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 2.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 12.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.3 | 1.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 1.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.3 | 4.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 2.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 1.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 3.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 3.4 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 2.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 4.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 2.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 3.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 2.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 0.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 0.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 2.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.3 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 0.3 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.3 | 0.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 0.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 1.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 13.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 2.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 3.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 0.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 3.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 1.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 3.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 3.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 2.7 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 8.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 7.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 1.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 0.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 3.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 3.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 1.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 4.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 2.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 7.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 12.5 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 2.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 1.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 2.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 6.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 2.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 3.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 7.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 5.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 0.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 0.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 1.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.1 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 1.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 1.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 1.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 5.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.4 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 2.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 1.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 1.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 5.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 5.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 11.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 1.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 1.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.6 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 4.5 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 6.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 2.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 7.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.2 | GO:0030523 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.2 | 0.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 7.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.7 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.7 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.2 | 6.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.7 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 1.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 7.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 2.4 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 1.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 4.5 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.2 | 1.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.5 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.2 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 0.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 2.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.5 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 4.5 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 12.1 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 15.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 2.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.9 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 2.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 3.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 1.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.6 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 1.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 2.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 1.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 3.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0052629 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 13.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 1.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 18.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.6 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 4.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 1.8 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 3.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.4 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.7 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.9 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.5 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.1 | 0.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.5 | GO:0061505 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 4.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 5.3 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 5.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.4 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.1 | 2.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.6 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 7.3 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.1 | 2.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 3.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 2.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.8 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 5.9 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 8.3 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 2.6 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 1.8 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 0.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 1.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.1 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 2.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 3.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 6.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 8.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 2.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 4.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 3.4 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 1.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 4.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 8.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 20.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0018631 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 2.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 2.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 6.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 1.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 4.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.9 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.1 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 2.1 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 3.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 3.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 1.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 4.9 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 22.5 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 6.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 1.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 2.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 0.3 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 3.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 10.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.2 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.7 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 32.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 10.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 3.9 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 1.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.4 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.6 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.3 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.4 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 1.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 1.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.0 | 4.6 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 3.7 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 1.0 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 0.1 | GO:0043178 | alcohol binding(GO:0043178) |
0.0 | 0.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 3.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.1 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.0 | 1.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 5.0 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0015932 | nucleoside transmembrane transporter activity(GO:0005337) nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 7.8 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 1.8 | GO:0001653 | peptide receptor activity(GO:0001653) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 9.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.0 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 18.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.0 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 4.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.1 | 9.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 12.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 12.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 9.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 3.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 3.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 11.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 23.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 20.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 8.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 15.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 5.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 8.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 12.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 6.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 6.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 1.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 9.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 8.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 6.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 6.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 8.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 5.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 2.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 1.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 1.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 1.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 8.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 15.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 6.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 3.8 | PID ATM PATHWAY | ATM pathway |
0.2 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 2.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 3.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 6.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 1.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 5.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 4.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 4.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 4.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 3.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 3.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 2.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 2.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 6.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.2 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 3.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 2.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 10.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.1 | 1.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
1.1 | 11.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.9 | 10.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.8 | 7.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.8 | 7.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 11.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.7 | 11.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.7 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.7 | 8.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 10.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 7.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 6.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 5.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 9.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 6.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 13.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 3.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 7.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 0.9 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.5 | 7.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 0.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.5 | 13.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 4.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 3.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 0.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 3.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 1.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 24.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 3.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 3.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 4.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 10.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 4.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 0.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 6.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 0.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 3.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 4.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 2.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 1.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 3.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 3.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 5.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 8.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 5.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 1.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 1.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 2.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 2.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 1.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 3.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 22.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 4.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 4.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 15.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 4.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 1.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 4.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 5.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 11.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 3.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 4.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 2.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 3.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 2.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 11.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 2.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 2.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 4.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 13.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.0 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 1.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 0.3 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.2 | 1.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 8.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 2.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 3.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 5.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 4.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 0.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 4.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 3.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 3.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 2.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 3.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 3.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 2.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 6.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 4.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 6.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 14.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 4.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.7 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 5.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 2.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 13.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.4 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 5.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.9 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.8 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 3.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 1.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.2 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.0 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |